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Purpose: To establish an untransfected human corneal endothelial (HCE) cell line and characterize its biocompatibility
to denuded amniotic membrane (dAM).
Methods: Primary culture was initiated with a pure population of HCE cells in DMEM/F12 media (pH 7.2) containing
20% fetal bovine serum and various supplements. The established cell line was characterized by growth property,
chromosome analysis, morphology recovery, tumorigenicity assay, and expression of marker proteins, cell-junction
proteins, and membrane transport proteins. The biocompatibility of HCE cells to dAM was evaluated by light microscopy,
alizarin red staining, immunofluorescence assay, and electron microscopy.
Results: HCE cells proliferated to confluence 6 weeks later in primary culture and have been subcultured to passage 224
so far. A continuous untransfected HCE cell line with a population doubling time of 26.20 h at passage 101 has been
established. Results of chromosome analysis, morphology, combined with the results of expression of marker protein,
cell-junction protein and membrane transport protein, suggested that the cells retained HCE cell properties and potencies
to form cell junctions and perform membrane transport. Furthermore, HCE cells, without any tumorigenicity, could form
confluent cell sheets on dAMs. The single layer sheets that attached tightly to dAMs had similar morphology and structure
to those of HCE in situ and had an average cell density of 3,413±111 cells/mm2.
Conclusions: An untransfected and non-tumorigenic HCE cell line has been established, and the cells maintained positive
expression of marker proteins, cell-junction proteins and membrane transport proteins. The cell line, with excellent
biocompatibility to dAM, might be used for in vitro reconstruction of HCE and provides a promising method for the
treatment of diseases caused by corneal endothelial disorders.
The human corneal endothelium (HCE) is the single layer
of cells, located at the posterior end of the cornea between the
stromal  layer  and  the  aqueous  humor,  that  is  critically
involved in maintaining corneal thickness or transparency
[1]. The density of HCE cells decreases with age [2], disease
[3], intraocular surgery [4], or laser procedures [5]. Repair of
mature HCE monolayer in response to cell loss occurs mainly
by cell enlargement and migration [6]. Although adult HCE
cells have lost their proliferative activity, arrested in G1-phase
in vivo, and are generally difficult to be cultured in long-term,
they do retain proliferative capacity [1,7].
HCE cell lines could provide efficient models for studies
of cellular specification, cellular signaling, cell replacement,
in vitro reconstruction of tissue-engineered HCE (TE-HCE),
immunology of HCE graft rejection, and molecular pathways
regulating  normal  HCE  cell  homeostasis  [7,8].  The  main
difficulties encountered in establishing HCE cell lines are
maintenance of morphological differentiation and functional
status,  induction  of  their  proliferation,  and  prevention  of
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keratocyte/fibroblast  overgrowth  [9].  Although  numerous
attempts have been made to cultivate HCE cells for protracted
periods in vitro [7,8,10,11], cultured HCE cell lines have only
been developed by transfection with viral oncogenes coding
for Ha-ras, SV40 large T antigen and HPV16 E6/E7 [12-15].
The effectiveness of these transfected cell lines as potential
research models has been hampered by genetic instability,
abnormal phenotypes, and tumorigenicity, precluding their
effective use in studies of normal endothelial cell biology and
clinical  corneal  endothelial  cell  replacement  [16].  No
untransfected HCE cell line has been established before this
study,  except  for  the  two  untransfected  rabbit  corneal
endothelial cell lines that we established previously [16,17].
Since no definitive markers for HCE cells have been
identified, HCE cells can only be characterized with various
marker proteins such as neuron specific enolase (NSE), type
IV collagen, and vascular endothelial growth factor receptor
II  (FLK-1),  various  cell-junction  proteins  such  as  zonula
occludens protein 1 (ZO-1), N-cadherin, connexin 43 and
integrin αv/β5, and various membrane transport proteins such
as aquaporin 1 (AQP1), Na+/K+-ATPase, voltage-dependent
anion channels (VDACs), chloride channel proteins (ClCs),
sodium  bicarbonate  cotransporter  4  (NBC1),  and  cystic
fibrosis  transmembrane  conductance  regulator  (CFTR)  [9,
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46912-18]. To provide a viable model for studying HCE cells and
reconstruction of TE-HCE for clinical HCE replacement, the
present  study  was  intended  to  establish  a  continuous
untransfected HCE cell line, characterize its intrinsic property
and  its  biocompatibility  to  denuded  amniotic  membranes
(dAMs).
METHODS
Animals and materials: Corneas from a woman (26 years old)
who died due to cerebral hemorrhage were obtained from The
Affiliated Hospital of Medical College, Qingdao University
(Qingdao, China), with permission from her next of kin. The
usage of the corneas as the source of HCE cells for in vitro
culture was approved by the Medical Ethics Committee of the
hospital  and  the  privacy  of  the  patient  was  protected  in
compliance with the Declaration of Helsinki. SPF BalB/c
nude mice (male), weighing 18 to 22 g, were purchased from
Slaccas Experimental Animal Co., Ltd. (Shanghai, China). All
animals were treated in accordance with the ARVO Statement
for usage in tumorigenesis assay, and were approved by the
Clinical Research Ethics Committee of New Drug Evaluation
Center, Shandong University (Jinan, China).
Fresh  amniotic  membranes  (AMs),  stored  in  −20  °C
glycerol,  were  obtained  from  Shandong  Eye  Institute  of
Shandong Medical Academy. The AMs were washed twice
with 0.9% physiologic saline and disinfected with 1,000 IU/
ml  tobramycin  for  20  min.  After  a  further  wash  with
physiologic saline, the AMs, with the epithelial surface down,
were spread uniformly without folds on filter papers fully
immersed  in  0.02%  EDTA-0.25%  trypsin  (1:1;  Sigma-
Aldrich, St. Louis, MO) solution. After digestion at 37 °C for
30 min, AMs were washed and their epithelial surfaces were
scraped gently with a sterile cell-scraper to obtain denuded
AMs (dAMs). Human corneal stromal (HCS) cells, from an
HCS cell line established in our laboratory, were cultured in
Dulbecco’s  Modified  Eagle’s  Medium/Ham’s  Nutrient
Mixture F12 (DMEM/F12, 1:1) medium (pH 7.2; Invitrogen,
Carlsbad,  CA)  containing  20%  bovine  calf  serum  (BCS;
Invitrogen) at 37 °C with 5% CO2. During logarithmic phase,
the  culture  supernatant  of  HCS  cells  was  collected  and
centrifuged at 2,000× g for 30 min.
In vitro culture of HCE cells: In vitro culture of HCE cells
was  initiated  as  described  previously  [16].  Donated  fresh
human corneas were placed flatly in a 35 mm culture dish.
About 0.5 ml of 0.25% trypsin was infused into their hollows
for  digestion  of  about  2  min.  The  trypsin  solution  was
discarded  and  the  corneas  were  rinsed  with  10%  BCS-
DMEM/F12  medium  (pH  7.2;  Invitrogen)  and  cut  into
quarters. The quartered pieces were attached directly onto a
0.05%  gelatin  (Sigma-Aldrich)-coated  wells  of  a  24  well
culture plate with their endothelial surface down, and cultured
in  10%  fetal  bovine  serum  (FBS)-DMEM/F12  medium
(Invitrogen) at 37 °C with 5% CO2. The corneal pieces were
detached and re-attached sequentially into new gelatin-coated
wells  for  a  time  interval  of  36  h,  24  h,  12  h  and  6  h,
respectively. The wells containing only a pure population of
HCE cells were selected, and the cells in these wells were
collected. The pure HCE cells were resuspended in 1 ml of
20% FBS-containing DMEM/F12 medium with antibiotics,
and split into two new gelatin-coated wells and cultured at
37 °C with 5% CO2. Twenty-four h later, the culture medium
was  further  supplemented  with  10  ng/ml  basic  fibroblast
growth  factor  (bFGF),  10  ng/ml  epidermal  growth  factor
(EGF), 50 μg/ml N-acetylglucosamine hydrochloride, 50 μg/
ml glucosamine hydrochloride, 0.8 mg/ml chondroitin sulfate,
50  μg/ml  oxidation-degradation  products  of  chondroitin
sulfate  (all  obtained  Sigma-Aldrich),  50  μg/ml
carboxymethyl-chitosan (AK Scientific, Mountain, CA), 5
ng/ml bovine ocular extracts (Bosen Biologic Pharmaceutical
Inc., Xi’an, China), and 10% (v/v) culture supernatant of HCS
cells at logarithmic phase. The primary culture was initiated
at  37  °C  with  5%  CO2  with  medium  refreshed  at  5  day
intervals. Once a confluent monolayer had formed, HCE cells
were subcultured with 0.25% trypsin as described previously
[17]. Briefly, the trypsin-digested HCE cells were suspended
and inoculated into new culture wells at a ratio of 1:2, and the
same method was used during subsequent subcultures of HCE
cells. From passage 30, the cells were subcultured in 20%
FBS-containing DMEM/F12 medium without growth factors
and the other supplements as described above.
Growth properties: Passage 101 HCE cells were harvested
and suspended in 20% FBS-DMEM/F12 medium to a density
of 2.0×105 cell/ml, and the growth properties of the cells were
measured as previously described [17]. Briefly, the number of
HCE cells in each well was counted at a 12 h interval, and the
average value of 3 wells was used to plot their growth curve.
Data shown are the mean±SD of three experiments (n=3), and
the mean value of cell density was used to protract the growth
curve and calculate the population doubling time of HCE
cells.
Chromosome analysis: The chromosome specimens of the
passage 101 HCE cells at logarithmic phase were prepared as
previously described [17]. Briefly, harvested HCE cells were
suspended in 0.3% KCl hypotonic solution and fixed with
Carnoy’s solution, and chromosome specimens were stained
with Giemsa after being air dried. Chromosome numbers of
300 metaphase cells were counted under an E200 microscope
(Nikon, Tokyo, Japan) and statistically analyzed.
Morphology recovery: Morphology recovery of HCE cells at
passage  101  was  performed  with  5%,  10%,  15%  BCS-
supplemented  MEM,  DMEM  and  DMEM/F12  medium
(Invitrogen),  respectively,  as  previously  described  [17].
Briefly, the HCE cells in different BCS-containing mediums
were all cultured at 37 °C with 5% CO2. The medium was
refreshed at 3-day intervals with the same BCS-containing
medium, respectively, and the morphological changes of HCE
cells were monitored daily under a Nikon E200 microscope
(Nikon, Tokyo, Japan).
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470Determination of protein expression by western blot: Total
protein  was  extracted  from  passage  101  HCE  cells,  and
18 μl of protein extracts were directly applied to 7.5% sodium
dodecylsulfate  polyacrylamide  gel.  Gel  samples  were
electrophoresed  and  electroblotted  onto  a  0.45  μm
nitrocellulose  membrane  using  an  electroblotting  system
(ATTO,  Tokyo,  Japan)  according  to  the  manufacturer’s
instructions. After blocking with 10% BCS (Invitrogen) for 1
h at 37 °C, the blots were probed with mouse anti-human
monoclonal antibodies of collagen type IV, von Willebrand
factor  (vWF),  FLK-1,  and  keratin  12  (1:500;  Millipore,
Billerica, MA) overnight at 4 °C, respectively. The negative
control blots were incubated with 0.05 M Tris-NaCl buffered
saline  (TBS)  (pH7.2).  Horseradish  peroxidase  (HRP)-
conjugated  goat  anti-mouse  IgG  (1:500;  Biosynthesis
Biotechnology,  Beijing,  China)  was  used  as  secondary
antibodies.  The  blots  were  developed  with  kits  of  3,30-
diaminobenzidine tetrahydrochloride (DAB) in TBS (pH7.2;
Biosynthesis Biotechnology).
Determination  of  protein  expression  by
immunocytochemistry:  Immunocytochemistry  of  NSE
expression of HCE cells at passage 101 was performed with
rabbit  anti-human  NSE  (1:100;  Signet  Laboratory  Inc.,
Dedham, MA), HRP-conjugated AffiniPure goat anti-rabbit
IgG  (1:100;  Biosynthesis  Biotechnology)  and  DAB  kits
(Biosynthesis Biotechnology) as previously described [17].
Briefly,  after  being  fixed  with  methanol  (Sigma-Aldrich),
treated  with  0.5%  Triton  X-100  (Sigma-Aldrich)  and  3%
H2O2  (Sigma-Aldrich),  and  blocked  with  5%  BCS
(Invitrogen), the HCE cells cultured on coverslips were in turn
incubated with rabbit anti-human NSE and HRP-conjugated
goat anti-rabbit IgG, and DAB kit stained specimens were
photographed with a Nikon E200 microscope. Omission of
primary antibodies was used as negative controls.
Immunofluorescence  staining  of  cell-junction  protein
expression of HCE cells at passage 101 was performed with
goat  anti-human  zonula  occludens  protein  1  (ZO-1)
polyclonal antibody (1:50; Santa Cruz Biotechnology, Santa
Cruz,  CA),  mouse  anti-human  N-cadherin  monoclonal
antibody (1:50; Santa Cruz), mouse anti-human connexin 43
monoclonal  antibody  (1:250;  Chemicon,  Temecula,  CA),
mouse anti-human integrin αv/β5 monoclonal antibody (1:50;
Santa  Cruz),  and  fluorescent  isothiocyanate  (FITC)-
conjugated  rabbit  anti-goat  IgG  antibody  or  rhodamine  B
isothiocyanate  (RBITC)-conjugated  goat  anti-mouse  IgG
antibody or FITC-conjugated goat anti-mouse IgG antibody
(1:100; Biosynthesis Biotechnology) as previously described
[16], and visualized with a Nikon Eclipse TE2000-U inverted
fluorescent microscope (Nikon, Tokyo, Japan). Briefly, after
being  fixed  with  4%  paraformaldehyde  (Sigma-Aldrich),
treated with 0.5% Triton X-100 (Sigma-Aldrich), and blocked
with 5% BCS (Invitrogen), the HCE cells were incubated with
ZO-1, N-cadherin, connexin 43, and mouse integrin αv/β5
antibody,  respectively,  and  then  incubated  with  FITC-
conjugated rabbit anti-goat IgG or RBITC-conjugated goat
anti-mouse IgG or FITC-conjugated goat anti-mouse IgG.
Omission of primary antibodies was used as negative controls.
Determination of mRNA expression by real-time PCR: Real-
time PCR was performed according to the methods described
by Xiao et al. [19]. Total RNAs of primary cultured and
subcultured  HCE  cells  were  extracted  with  NucleoSpin
RNAII Assay Kit (Macherey-Nagel, Germany), respectively.
The first strand cDNA was synthesized from 2 μg of total RNA
in a 20 μl reaction mixture with PrimeScriptTM 1st Strand
cDNA  Synthesis  kit  (Takara,  Ishiyama,  Japan).  Real-time
PCR of target genes, including human aquaporin 1 (AQP1),
Na+/K+-ATPase  α1  polypeptide  (ATP1A1),  voltage-
dependent anion channel 2 and 3 (VDAC2, VDAC3), chloride
channel protein 2 and 3 (ClC2, ClC3), sodium bicarbonate
cotransporter 4 (NBC1), and cystic fibrosis transmembrane
conductance regulator (CFTR), was performed on the ABI
Prism  7500  System  (ABI,  Foster  City,  CA).  The  primer
sequences for these reactions were designed on the basis of
the  published  human  gene  sequences  (Table  1).  The
housekeeping  gene  of  human  glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) was used as an internal control.
Quantification of the amplified product was done on a cycle-
by-cycle  basis  via  the  acquisition  of  a  fluorescent  signal
generated by binding of the fluorophore SybrGreen I (Roche
Diagnostics, Shanghai, China) to double-stranded DNA. Each
sample was assayed in duplicate with Taqman Universal PCR
Master  Mix  (Applied  Biosystems,  Foster  City,  CA).  The
cycling conditions were as follows: 10 min at 95 °C and 40
cycles of amplification for 15 s at 95 °C and 1 min at 60 °C.
The quantification data were analyzed with the 7500 System
Software  (Applied  Biosystems)  according  to  the
manufacturer’s instructions. Data shown are the mean±SD of
three experiments.
Tumorigenesis asay: Tumorigenesis assay of the HCE cells at
passage  101  was  performed  as  previously  described  [16].
About 1.0×107 HCE cells at logarithmic phase was inoculated
subcutaneously into one of the forehand oxters of each of 10
BalB/c nude mice respectively (n=10), while 10 BalB/c nude
mice inoculated with 1.0×107 HeLa cells per mouse were used
as positive controls. The tumorigenic status of the inoculated
mice was monitored daily. After 60 days, the skin of the oxter
of inoculated mice was surgically opened and tumorigenic
status was examined.
Biocompatibility to dAMs: Biocompatibility assay of HCE
cells to dAM was performed as previously described [16].
Passage 101 HCE cells at logarithmic phase were collected,
and the density of cell suspension was adjusted to 1.67×106
cell/ml with 20% FBS-containing DMEM/F12 medium. Then
1 ml cell suspension was plated into 24 well culture plates
coated with dAMs, and cultured at the same conditions as
described above. Culture medium was refreshed entirely at 3
day intervals and the morphology and growth status were
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471monitored daily. The morphology of cell sheets formed was
examined with a Nikon Eclipse TS100 inverted microscope
and a JSM2840 scanning electron microscope (SEM; JEOL,
Tokyo, Japan). The cell junction status was evaluated with 1%
alizarin  red  staining  and  immunocytochemistry  (the  same
method as described above). The continuous monolayer state
of HCE cell was examined by freeze section and hematoxylin-
eosin (HE) staining, and the attachment status of cell sheets
and dAMs were examined with a H700 transmission electron
microscope (TEM; Hitachi, Tokyo, Japan).
Statistical  analysis:  Data  are  expressed  as  mean±SD  in
triplicates  or  decuplicates  and  analyzed  for  statistical
significance with ANOVA single factor.
RESULTS
In vitro culture of HCE cells: Numerous pure HCE cells were
found to attach to the bottom of the wells when the corneal
pieces  were  detached  36  h  after  initiation  of  attachment
(Figure 1A). And these cells, with high transparency, were
almost  all  in  non-extended  hexagonal  or  polygonal
morphology. After the collected pure HCE cells were cultured
in 20% FBS-DMEM/F12 medium with various supplements,
the HCE cells grew into a confluent monolayer 6 weeks later
(Figure 1B). And the cells were plump and most of them in
polygonal morphology. During subsequent subculture, the
polygonal  morphology  of  HCE  cells  began  to  elongate
slightly (Figure 1C). Once subcultured in 20% FBS-DMEM/
F12  medium  without  growth  factors  and  the  other
supplements, the cells began to elongate into the fibroblast
morphology  (Figure  1D).  After  three  year’s  subculture,  a
novel  continuous  untransfected  HCE  cell  line  had  been
established and subcultured to passage 224 by now. The HCE
cells grew and proliferated at a steady rate, and their doubling
time was calculated to be 26.20 h at passage 101 (Figure 2).
Chromosome analysis of the HCE cell line: Chromosome
analysis  showed  that  HCE  cells  at  passage  101  exhibited
chromosomal aneuploidy with chromosome numbers ranged
from 41 to 50, and the ratio of HCE cells with a chromosome
number of 46 is about 47.8% (Figure 3), suggesting that the
modal chromosome number of the established HCE cell line
was still 46.
Morphology recovery of HCE cells: After passage 101 HCE
cells were cultured in 5%, 10% and 15% BCS-containing
MEM, DMEM, and DMEM/F12 medium, respectively, for 2
passages, morphological changes of the cells occurred. The
HCE cells cultured in 5% BCS-MEM medium underwent
dramatic  morphological  changes  from  fibroblastic  to
polygonal on day 10 (Figure 4), implying that the HCE cell
line still had inherent properties of corneal endothelial cells
without transdifferentiation.
Marker protein expression of HCE cells: Results of marker
protein expression are shown in Figure 5. Results of western
blot revealed that passage 101 HCE cells maintained positive
expression  of  type  IV  human  collagen  α2  polypeptide
(COL4A2)  and  human  vascular  endothelial  growth  factor
receptor 2 (FLK1), but not human von Willebrand Factor
(vWF)  and  human  keratin  12  (Figure  5A).  Results  of
immunocytochemistry showed that the HCE cells maintained
positive expression of NSE (Figure 5B). All these suggested
that the cells of the established cell line had properties of HCE
cells, not vascular endothelial cells or corneal epithelial cells.
Cell-junction  protein  expression  of  HCE  cells:
Immunofluorescence staining pattern of cell-junction proteins
TABLE 1. OLIGONUCLEOTIDE SEQUENCES USED IN THIS STUDY.
Name Sequence Accession
AQP1 (human aquaporin 1) F: 5-TGCCATCGGCCTCTCTGTAG-3 AB451275
  R: 5-AAGGACCGAGCAGGGTTAATC-3  
ATP1A1 (human Na+/K+ ATPase, alpha 1 polypeptide) F: 5-TCACTCCCCCTCCCACTACTC-3 BC003077
  R: 5-CATTGAGAACCCCCCAAAGA-3  
VDAC2 (human voltage-dependent anion channel 2) F: 5-CCTTGGTTGTGATGTTGACTTTGA-3 BC012883
  R: 5-CCAGCCCTCATAACCAAAGACA-3  
VDAC3 (human voltage-dependent anion channel 3) F: 5-AGGGTGGCTTGCTGGCTAT-3 BC056870
  R: 5-TTGTAACCCAGGGCGAAATT-3  
CLCN2 (human chloride channel protein 2) F: 5-CCTGGCTTTGGACAGTTCATG-3 AF026004
  R: 5-CCACGTCCGATTGTCAAACA-3  
CLCN3 (human chloride channel protein 3) F: 5-CAAGTCCACGAAATTTGGAAAGT-3 AF029346
  R: 5-TTAGGGAAGGCTATCACAGCAGTA-3  
NBC1 (human sodium bicarbonate cotransporter 4) F: 5-CCTCAGCTCTTCACGGAACTG-3 Q9Y6R1
  R: 5-GCTGTTTCCTTCCACTCCATCT-3  
CFTR (human cystic fibrosis transmembrane conductance regulator) F: 5-GCACGAAGGAGGCAGTCTGT-3 NM_000492
  R: 5-TGCTGTTGTCTTTCGGTGAATG-3  
GAPDH (human glyceraldehyde-3-phosphate dehydrogenase) F: 5-CTGCCCAGAACATCATCCCT-3 EU742868
  R: 5-GGTCCTCAGTGTAGCCCAAGA-3  
            Note: F: forward primers; R: reverse primers.
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472are  shown  in  Figure  6.  Positive  expression  of  ZO-1,  N-
cadherin, connexin 43, and integrin αv/β5 was detected in
passage  101  HCE  cells,  implying  that  the  cells  still  had
potential of forming intercellular and cell-extracellular matrix
(ECM) junctions.
Gene expression of membrane transport proteins in HCE
cells: Results of real-time PCR revealed that the HCE cells at
passage  101  still  maintained  the  expression  of  various
membrane transport protein genes such as AQP1, ATP1A1,
VDAC2, VDAC3, ClC2, ClC3, NBC1, and CFTR (Figure 7),
implying  that  the  cells  of  the  established  cell  line  had
properties of HCE cells and might have potentials to carry out
membrane transport functions.
Tumorigenicity of HCE cells: The results of tumorigenesis
assay were shown in Table 2. Solid tumors were found in all
10 BalB/c nude mice 7 days after inoculated with HeLa cells,
and grew progressively thereafter. However, no solid tumor
was found in 10 BalB/c nude mice 60 days after passage 101
HCE cells were inoculated. The results indicated that the
established HCE cell line had no tumorigenic potency.
Biocompatibility of HCE cells to dAMs: Passage 101 HCE
cells  grew  very  well  on  dAMs  and  formed  confluent
monolayer 116 h later with an average density of 3,413±111
cells/mm2 (Figure 8A). Most of the HCE cells were in slightly
elongated polygonal morphology (Figure 8B,C), and the cell
sheets they formed were continuous and intact that attached
tightly to dAM (Figure 8D,E). The HCE cells of the cell sheets
established various cell-cell and cell-dAM junctions (Figure
8F). These data suggested that the established HCE cell line
had  excellent  biocompatibility  to  dAM,  and  could  form
confluent cell sheets on dAMs with various intercellular and
cell-dAM  junctions.  Positive  expressions  of  ZO-1,  N-
cadherin, connexin 43, and integrin αv/β5 were also detected
in the HCE cells on dAM (Figure 9). All these indicated that
the HCE cells had excellent biocompatibility to dAM, and the
cells and dAM might be used for in vitro reconstruction of TE-
HCE.
DISCUSSION
HCE  cell  lines  are  necessary  in  studies  of  HCE  cell
proliferation,  differentiation,  apoptosis,  and  TE-HCE
reconstruction [16,17,20]. Even though numerous attempts
have been made to obtain HCE cells in long-term culture, two
main difficulties need to be surmounted in initiation of in vitro
culture and successful subculture of the cells [7,8,10-15]. One
is the difficulty in getting pure HCE cells, and the other is the
difficulty in inducing HCE cells to divide in vitro [16,17].
Based  on  our  previous  experiences  in  rabbit  corneal
endothelial cell line establishment, manipulations of strictly
controlled  trypsin  digestion,  direct  corneal  fragment
attaching, and successive detaching-reattaching of different
durations were also used to obtain pure and enough HCE cells
for primary culture initiation in the present study [16,17]. In
addition,  proliferation  of  HCE  cells  has  been  induced
successfully in the present study by replenishing the culture
medium  with  various  supplements,  such  as  chondroitin
sulfate,  glucosamine  hydrochloride,  N-acetylglucosamine
hydrochloride, growth factors, ocular extracts, and culture
supernatant of corneal stromal cells. The successful induction
Figure 1. In vitro culture of HCE cells.
A: HCE cells 36 h after plating, showing
the  non-spread  polygonal  cell
morphology,  i.e.,  corneal  endothelial-
like  morphology.  B:  The  monolayer
formed  by  HCE  cells  6  weeks  after
primary culture initiation, showing the
plump polygonal cell morphology. C:
Passage 101 HCE cells, showing the co-
existence of endothelioid and fibroblast-
like morphology. D: Passage 224 HCE
cells,  showing  the  co-existence  of
elongated polygonal and fibroblast-like
morphology. Scale bar: 50 μm.
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473of proliferation of HCE cells was consistent with the results
obtained in cultured HCE cells [21,22] and rabbit corneal
endothelial cells [16,17].
With  pure  HCE  cells  and  supplements-induced
proliferation, a continuous untransfected HCE cell line, with
the modal chromosome number of 46, had been successfully
established and subcultured to passage 224 in this study. The
cells proliferated actively and constantly with a population
doubling time of 26.2 h at passage 101. The estimated cell
doubling time was faster than that of a previously established
immortalized HCE cell line (30.15±10.96 h) [15].
To characterize corneal endothelial cells, various marker
proteins  such  as  NSE  (a  neuroectodermal  origin  marker
protein of HCE cells), collagen type IV (a marker protein of
HCE cells), FLK1 (VEGF receptor 2, a marker protein of both
vascular and corneal endothelial cells), vWF (a marker protein
of vascular endothelial cells), and keratin-12 (a marker protein
of  corneal  epithelial  cells)  have  often  been  used  [14,16,
23-26]  and  were  also  employed  in  this  study.  Positive
expression of NSE, collagen type IV and FLK1, but not vWF
and keratin 12, combined with the results of morphology
recovery suggests that the HCE cell line established in this
study was of a corneal endothelial origin, consistent with the
results obtained in previous studies of HCE cells [13,27] and
rabbit corneal endothelial cells [16,17]. Taken together, these
results indicated that established cell line was a pure HCE cell
line without contamination of corneal epithelial and stromal
cells.
Since cell junctions are crucial for HCE cells to maintain
intact  endothelium  for  achieving  stable  corneal  hydration
status, determination of the expression of junction proteins
was vital in HCE cell characterization [16]. HCE cells have
been  found  to  have  tight  junction  proteins,  gap  junction
proteins, and anchoring junction proteins, which mediate and
strengthen cell-cell and cell-matrix associations [16,28-30].
In this study, HCE cells at passage 101 still maintained stable
Figure 2. The growth curve of HCE cells
at  passage  101.  The  cells  had  a
population  doubling  time  of  26.20  h.
The results represent means±SD (n=3).
Lag,  lag  phase;  Log,  exponential  or
logarithmic phase; Sta, stationary phase;
Dec, decline phase.
Figure 3. Chromosome analysis of HCE
cells at passage 101. A: The HCE cells
had  chromosomal  aneuploidy  with
chromosome numbers ranged from 41
to  50.  Among  them,  HCE  cells  with
chromosome number of 46 were about
47.8%. B: Diploid karyotype of a HCE
cell with a chromosome number of 46.
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474expression of ZO-1 (an intercellular tight junction protein),
connexin-43  (an  intercellular  gap  junction  protein),  N-
cadherin (an intercellular anchoring junction protein), and
integrin  αv/β5  (a  cell-matrix  anchoring  junction  protein),
suggesting that the HCE cells still maintained potency to
establish  normal  cell-cell  and  cell-ECM  junctions.  This
expression pattern of cell junction proteins in HCE cells is
consistent  with  the  results  obtained  from  rabbit  corneal
endothelial cells [16], but is different from that of in vitro
cultured HCE cells [31].
Membrane  transport  proteins  of  HCE  cells,  such  as
AQP1, Na+/K+-ATPase, VDACs, CLCs, NBC1 and CFTR,
play  crucial  roles  in  maintaining  corneal  dehydration  and
transparency [16,32-34]. Among these, AQP1 is important for
osmotically driven water transport [35], and Na+/K+-ATPase
for maintaining corneal dehydration and transparency [36],
VDACs  for  anion  transport  [37,38],  CLCs  for  chloride
transport  [39,40],  NBC1  for  the  cotransport  of  Na+  and
HCO3
- [41], and CFTR for HCO3
- transport [42,43]. In the
present  study,  the  maintenance  of  gene  expressions  of
AQP1,ATP1A1,VDAC2,VDAC3,CLC2,CLC3,NBC1,  and
CFTR, indicated that the established HCE cell line still had
potencies to carry out normal functions of transmembrane
transport,  consistent  with  the  results  obtained  from  rabbit
corneal endothelial cell lines [16].
Figure 4. Morphology recovery of HCE
cells at passage 101. A: Control HCE
cells cultured in 20% FBS-containing
DMEM/F12 (1:1) medium, showing the
fibroblastic morphology. B: HCE cells
cultured in 5% BCS-containing MEM
medium,  showing  the  more  corneal
endotheloid-like  morphology.  Scale
bar: 50 μm.
Figure 5. Expression of marker proteins
of HCE cells at passage 101. A: western
blot, showing the positive expression of
COL4A2  and  FLK1,  and  negative
expression of vWF and keratin 12 of
HCE  cells.  B:  immunocytochemistry,
showing the positive expression of NSE.
COL4A2, type IV human collagen α2
polypeptide;  FLK1,  human  vascular
endothelial  growth  factor  receptor-2;
vWF,  human  von  Willebrand  Factor;
keratin  12,  human  keratin  12;  NSE,
neuron specific enolase.
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475Immortalized corneal endothelial cell lines by oncogene
transfections may have latent potency of tumorigenicity and
abnormal phenotypes, and cannot be used in studies of HCE
cells and reconstruction of the ocular surface with a tissue-
engineered cornea [16,17]. Tumorigenic potency assay with
nude mice in this study showed that the HCE cell line had no
latent potency for tumorigenicity, suggesting that the HCE
cell line established in this study could be safely used in
studies of HCE cells and in vitro reconstruction of TE-HCEs.
Excellent  biocompatibility  between  corneal  cells  and
scaffold  carriers  is  a  vital  precondition  for  in  vitro
reconstruction of tissue-engineered corneas [16,44]. Among
the scaffold carriers used, dAM has been proving to have
excellent biocompatibility to HCE cells and successfully used
in TE-HCE reconstruction [26,27]. In the present study, the
Figure 6. Immunofluorescence staining
patterns  of  cell-junction  proteins  of
HCE cells at passage 101. A: human
zonula occludens protein 1 (ZO-1). B:
human  N-cadherin.  C:  human
connecxin-43. D: human integrin αv/β5.
Positive expression of the cell-junction
proteins of HCE cells was shown. Scale
bar: 50 μm.
Figure 7. Real time PCR detection of the
gene expression of membrane transport
proteins of HCE cells at passage 101.
Positive  gene  expression  patterns  of
various membrane transport proteins of
HCE cells were shown. AQP1, human
aquaporin 1 gene; ATP1A1, human α1
polypeptide  of  Na+/K+-ATPase  gene;
VDAC, human voltage-dependent anion
channel  gene;  CLC,  human  chloride
channel  protein  gene;  NBC1,  human
sodium  bicarbonate  cotransporter  4
gene;  CFTR,  human  cystic  fibrosis
transmembrane  conductance  regulator
gene. The housekeeping gene, human
glyceraldehyde-3-phosphate
dehydrogenase (GAPDH), was used as
an internal control.
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476cells from established HCE cell line formed confluent cell
sheets  on  dAMs  with  various  intercellular  and  cell-dAM
junctions. And the average cell density of the HCE cell sheets
on dAMs was about 3,413±111 cells/mm2, similar to that of a
10–11 years old child [45], which was much higher than those
of previous reports [26,27,46]. These results indicate that the
HCE cells could form integral endothelium-like structures on
dAMs, consistent with the results obtained from passage 5
HCE cells and immortalized HCE cells on dAMs [26,27]. The
excellent biocompatibility to dAMs and high cell density of
reconstructed cell sheets imply that the established HCE cell
line might be feasible for reconstruction studies of TE-HCE
[47].
In  conclusion,  a  continuous  untransfected  and  non-
tumorigenic HCE cell line, with normal protein expression
and excellent biocompatibility to dAMs, has been established
successfully  in  this  study.  And  the  cell  line  provides  a
powerful tool for studies of proliferation, differentiation and
apoptosis of HCE cells. It could also be used for reconstruction
of TE-HCE, providing a promising method for the treatment
of diseases caused by corneal endothelial disorders. Studies
TABLE 2. TUMORIGENESIS ASSAY OF PASSAGE 101 HCE CELLS IN BALB/C NUDE MICE.
Inoculated cells Total dose (cell/mouse) Number of mice (% mortality) Number of mice with tumor
HCE cells 1.0×107 10 (0) 0
HeLa cells 1.0×107 10 (0) 10
          Note: tumors were identified surgically.
Figure 8. Evaluation of biocompatibility
of passage 101 HCE cells on dAMs. A:
The confluent cell sheet formed by HCE
cells on dAM 116 h after inoculation.
The  cell  density  and  elongated
polygonal  morphology  were  shown.
Scale bar: 25 μm. B: alizarin red staining
pattern of the HCE cell sheet. The cell
density,  elongated  polygonal
morphology  and  established
intercellular  junctions  were  shown.
Scale bar: 25 μm. C: SEM image of the
HCE cell sheet. The confluent cell sheet
and elongated polygonal morphology of
HCE cells were shown. Scale bar: 25
μm. D: hematoxylin-eosin (HE) staining
pattern of the frozen section of the HCE
cell sheet. The confluent monolayer cell
sheet formed by HCE cells on dAM was
shown.  Scale  bar:  100  μm.  E:  TEM
image of the HCE cell sheet. The tightly
attaching  status  of  the  cell  sheet  and
dAM was shown. Scale bar: 4 μm. F:
TEM image of the HCE cell sheet. The
ultrastructure  of  HCE  cells,  the
established  cell-cell  junctions  (arrow
heads)  and  cell-dAM  junctions
(asterisk) were shown. Scale bar: 500
nm.
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477on TE-HCE reconstruction and its animal transplantation are
currently underway in our laboratory.
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